Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 17/20 | 0.73 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.68 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18308677 | 1.00 | FOLH1 (0.73) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL15384692 | 1.00 | FOLH1 (0.73) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL18308678 | 1.00 | FOLH1 (0.73) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL14194625 | 1.00 | FOLH1 (0.73) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL10283022 | 1.00 | FOLH1 (0.73) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL23783591 | 1.00 | FOLH1 (0.73) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL21339332 | 0.98 | FOLH1 (0.71) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL16374659 | 0.95 | FOLH1 (0.70) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL30255156 | 0.94 | FOLH1 (0.66) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL24729088 | 0.94 | FOLH1 (0.66) | FOLH1NAALAD2RIMKLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022032353-A1 | RADIOPHARMACEUTICALS, USES THEREOF, AND METHODS FOR THE PRODUCTION THEREOF | Clarity Pharmaceuticals Ltd (AU) | 2022-02-17 | — | — | WO | disclosed |
| WO-2020065045-A1 | LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PSMA-EXPRESSING CANCERS | Universität Heidelberg (DE) | 2020-04-02 | — | — | WO | disclosed |